MedPath

Norethindrone Acetate

Norethindrone Acetate Tablets, USP Rx Only

Approved
Approval ID

827c7ef1-a8b7-d0c4-b062-c5154b331a35

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2024

Manufacturers
FDA

AvKARE

DUNS: 796560394

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42291-650
Application NumberANDA200275
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 10, 2024
FDA Product Classification

INGREDIENTS (4)

LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
NORETHINDRONE ACETATEActive
Quantity: 5 mg in 1 1
Code: 9S44LIC7OJ
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norethindrone Acetate - FDA Drug Approval Details